Huma Dar

About me

Article: JOURNAL OF CLINICAL ONCOLOGY. 2022;40(35):4071-4082
Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial
Johansson A; Dar H; Veer LJVT; Tobin NP; Perez-Tenorio G; Nordenskjold A; Johansson U; Hartman J; Skoog L; Yau C; Benz CC; Esserman LJ; Stal O; Nordenskjold B; Fornander T; Lindstrom LS
Article: JAMA NETWORK OPEN. 2021;4(6):e2114904
Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial
Dar H; Johansson A; Nordenskjold A; Iftimi A; Yau C; Perez-Tenorio G; Benz C; Nordenskjold B; Stal O; Esserman LJ; Fornander T; Lindstrom LS
Article: INTERNATIONAL JOURNAL OF CANCER. 2016;139(11):2415-2425
Worse quality of life in young and recently diagnosed breast cancer survivors compared with female survivors of other cancers: A cross-sectional study
Li J; Humphreys K; Eriksson M; Dar H; Brandberg Y; Hall P; Czene K

Affiliated to Research, Department of Oncology-Pathology, Karolinska Institutet, 2024-2025

Degree Of Doctor Of Philosophy, Department of Oncology-Pathology, Karolinska Institutet, 2023
Degree Of Master Of Medical Science 120 Credits, Karolinska Institutet, 2015